tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cellectis files $200M mixed securities shelf
PremiumThe FlyCellectis files $200M mixed securities shelf
2M ago
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
Premium
Ratings
Cautious Hold on Cellectis SA Amid Anticipated Data Releases and Strategic Developments
4M ago
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
Premium
Ratings
Cellectis SA: Hold Rating Amid Stable Financials and Promising Collaborations, Yet Cautious Outlook Due to Market and Clinical Uncertainties
4M ago
Cellectis Reports 2024 Financial Results and Strategic Progress
PremiumCompany AnnouncementsCellectis Reports 2024 Financial Results and Strategic Progress
6M ago
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
Premium
Ratings
Cellectis SA: Strategic Collaborations and Clinical Advancements Drive Buy Rating
6M ago
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
Premium
Company Announcements
Cellectis Reports 2024 Financial Results and Strategic Advances in CAR T-Cell Therapies
6M ago
Cellectis SA: Financial Growth Amidst Strategic Partnerships
PremiumCompany AnnouncementsCellectis SA: Financial Growth Amidst Strategic Partnerships
10M ago
Cellectis price target lowered to $5 from $7 at Barclays
Premium
The Fly
Cellectis price target lowered to $5 from $7 at Barclays
10M ago
Cellectis reports Q3 EPS (22c), consensus (21c)
Premium
The Fly
Cellectis reports Q3 EPS (22c), consensus (21c)
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100